CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society
ACS Journal Cancer
18 episodes
1 week ago
Introducing CancerSpeak, the official podcast of Cancer, a journal of the American Cancer Society. CancerSpeak is dedicated to bringing the best of science to the broadest audiences, offering the latest research, real-life stories, and expert perspectives from the field of oncology.
All content for CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society is the property of ACS Journal Cancer and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Introducing CancerSpeak, the official podcast of Cancer, a journal of the American Cancer Society. CancerSpeak is dedicated to bringing the best of science to the broadest audiences, offering the latest research, real-life stories, and expert perspectives from the field of oncology.
CancerSpeak Mini Episode 3: Updated Approaches to Appendiceal Tumors With Peritoneal Involvement
CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society
2 minutes 44 seconds
4 months ago
CancerSpeak Mini Episode 3: Updated Approaches to Appendiceal Tumors With Peritoneal Involvement
Dr. Elizabeth Godfrey is joined by Drs. Michael White and Mustafa Raoof to discuss “Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 2: Appendiceal Tumors With Peritoneal Involvement.” This article is part of a series published jointly in Cancer and Annals of Surgical Oncology entitled “Consensus Guidelines for the Management of Peritoneal Surface Malignancies.”
🔗 Read the full article in Cancer: https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35874
Music by Ivymusic from Pixabay.
CancerSpeak: A podcast from CANCER, a journal of the American Cancer Society
Introducing CancerSpeak, the official podcast of Cancer, a journal of the American Cancer Society. CancerSpeak is dedicated to bringing the best of science to the broadest audiences, offering the latest research, real-life stories, and expert perspectives from the field of oncology.